NASDAQ : NEUP
Neuphoria Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.05 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 16.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Neuphoria Therapeutics Inc. (NEUP) reported revenue of 1.17M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 1.17M | 1.17M | 15.65M | 181.64K | ||
| Other Revenue | 3.99M | |||||
| Revenue | 1.17M | 1.17M | 15.65M | 4.17M | ||
| Cost of Revenue | 11.02M | |||||
| Gross Profit | 1.17M | 1.17M | 15.65M | -6.85M | ||
| Selling, General & Admin | 7.44M | 7.44M | 7.77M | 8.47M | 8.91M | 5.28M |
| Research & Development | 2.74M | 2.74M | 8.71M | 9.32M | 12.65M | |
| Other Operating Expenses | -4.60K | |||||
| Operating Expenses | 10.18M | 10.18M | 16.48M | 17.80M | 21.56M | 5.27M |
| Operating Income | -9.01M | -9.01M | -829.19K | -17.80M | -21.56M | -12.12M |
| Interest Expense | -18.52K | |||||
| Interest & Investment Income | 665.57K | 665.57K | 166.50K | 220.10K | 323.16K | 6.80K |
| Currency Exchange Gain (Loss) | -535.72K | -535.72K | -415.00K | -209.84K | 308.85K | 245.40K |
| Other Non Operating Income (Expenses) | -592.63K | -2.59M | ||||
| EBT Excluding Unusual Items | -8.88M | -8.88M | -1.08M | -17.79M | -21.52M | -14.48M |
| Merger & Restructuring Charges | -1.28M | -1.28M | ||||
| Impairment of Goodwill | -5.36M | -5.36M | ||||
| Gain (Loss) on Sale of Investments | 1.93M | 1.93M | 239.69K | 2.21M | ||
| Gain (Loss) on Sale of Assets | -1.26K | |||||
| Other Unusual Items | -645.14K | |||||
| Pretax Income | -13.59M | -13.59M | -838.00K | -15.58M | -21.52M | -15.12M |
| Income Tax Expense | -139.17K | -139.17K | -468.37K | -87.32K | -139.17K | -132.15K |
| Earnings From Continuing Operations | -13.45M | -13.45M | -369.63K | -15.49M | -21.38M | -14.99M |
| Net Income | -13.45M | -13.45M | -369.63K | -15.49M | -21.38M | -14.99M |
| Net Income to Common | -13.45M | -13.45M | -369.63K | -15.49M | -21.38M | -14.99M |
| Shares Outstanding (Basic) | 4.40M | 4.40M | 1.62M | 832.23K | 1.47B | 1.35B |
| Shares Outstanding (Diluted) | 4.40M | 4.40M | 1.62M | 832.23K | 1.47B | 1.35B |
| EPS (Basic) | -3.06 | -3.06 | -0.23 | -18.62 | -0.01 | -0.01 |
| EPS (Diluted) | -3.06 | -3.06 | -0.23 | -18.62 | -0.01 | -0.01 |
| Free Cash Flow | -12.35M | -12.35M | 77.23K | -14.68M | -14.64M | -14.99M |
| Free Cash Flow Per Share | -2.81 | -2.81 | 0.05 | -17.64 | -0.01 | -0.01 |
| Gross Margin | 100.00% | 100.00% | 100.00% | -164.21% | ||
| Operating Margin | -767.32% | -767.32% | -5.30% | -290.62% | ||
| Profit Margin | -1,145.66% | -1,145.66% | -2.36% | -359.34% | ||
| Free Cash Flow Margin | -1,052.07% | -1,052.07% | 0.49% | -359.30% | ||
| EBITDA | -8.35M | -8.35M | -166.30K | -17.13M | -20.90M | -11.49M |
| EBITDA Margin | -1.06% | -275.36% | ||||
| D&A For EBITDA | 662.96K | 662.96K | 662.89K | 662.99K | 663.19K | 636.81K |
| EBIT | -9.01M | -9.01M | -829.19K | -17.80M | -21.56M | -12.12M |
| EBIT Margin | -5.30% | -290.62% | ||||
| Revenue as Reported | 1.17M | 1.17M | 15.65M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.87M | 19.87M | 14.21M | 12.61M | 12.10M | 23.13M |
| Cash & Short-Term Investments | 19.87M | 19.87M | 14.21M | 12.61M | 12.10M | 23.13M |
| Other Receivables | 813.43K | 813.43K | 11.95K | 126.88K | 426.09K | 4.67M |
| Receivables | 813.43K | 813.43K | 11.95K | 126.88K | 426.09K | 4.67M |
| Prepaid Expenses | 389.77K | 389.77K | 740.19K | 458.76K | 797.48K | 1.01M |
| Restricted Cash | 77.94K | |||||
| Total Current Assets | 21.07M | 21.07M | 15.04M | 13.19M | 13.33M | 28.81M |
| Property, Plant & Equipment | 105.38K | 218.97K | 333.00K | 464.74K | ||
| Goodwill | 3.50M | 3.50M | 8.64M | 8.69M | 8.69M | 8.87M |
| Other Intangible Assets | 4.14M | 4.14M | 4.80M | 5.47M | 6.13M | 6.78M |
| Other Long-Term Assets | 78.83K | 78.90K | 81.99K | |||
| Total Assets | 28.71M | 28.71M | 28.59M | 27.65M | 28.56M | 45.00M |
| Accounts Payable | 385.58K | 385.58K | 1.15M | 2.24M | 1.44M | 1.07M |
| Accrued Expenses | 283.49K | 283.49K | 2.88M | 1.39M | 1.19M | 1.13M |
| Short-Term Debt | 34.34K | 34.34K | 32.75K | 33.12K | ||
| Current Portion of Leases | 116.31K | 121.99K | 113.93K | 110.27K | ||
| Other Current Liabilities | 53.16K | 53.16K | 35.76K | 37.58K | ||
| Total Current Liabilities | 756.58K | 756.58K | 4.22M | 3.83M | 2.74M | 2.31M |
| Long-Term Leases | 117.63K | 239.84K | 367.63K | |||
| Pension & Post-Retirement Benefits | 7.21K | |||||
| Long-Term Deferred Tax Liabilities | 355.94K | 355.94K | 495.11K | 963.54K | 1.10M | 1.24M |
| Other Long-Term Liabilities | 3.00M | 3.00M | 4.87M | 5.25M | 2.47M | 1.86M |
| Total Liabilities | 4.11M | 4.11M | 9.59M | 10.16M | 6.55M | 5.79M |
| Common Stock | 54.00 | 54.00 | 19.00 | 11.00 | 149.99M | |
| Additional Paid-In Capital | 218.46M | 218.46M | 200.19M | 198.48M | 187.55M | |
| Retained Earnings | -191.80M | -191.80M | -178.35M | -177.98M | -162.48M | -119.41M |
| Comprehensive Income & Other | -2.06M | -2.06M | -2.85M | -3.01M | -3.06M | 8.63M |
| Shareholders' Equity | 24.60M | 24.60M | 19.00M | 17.49M | 22.01M | 39.21M |
| Total Liabilities & Equity | 28.71M | 28.71M | 28.59M | 27.65M | 28.56M | 45.00M |
| Total Debt | 34.34K | 34.34K | 149.06K | 272.74K | 353.76K | 477.90K |
| Net Cash (Debt) | 19.83M | 19.83M | 14.06M | 12.34M | 11.75M | 22.65M |
| Net Cash Per Share | 4.51 | 4.51 | 8.66 | 14.82 | 0.01 | 0.02 |
| Filing Date Shares Outstanding | 5.41M | 5.41M | 2.36M | 3.12B | 1.47B | 1.35B |
| Total Common Shares Outstanding | 5.41M | 5.41M | 1.98M | 2.38B | 1.47B | 1.35B |
| Working Capital | 20.31M | 20.31M | 10.82M | 9.36M | 10.59M | 26.49M |
| Book Value Per Share | 4.55 | 4.55 | 9.60 | 0.01 | 0.01 | 0.03 |
| Tangible Book Value | 16.96M | 16.96M | 5.56M | 3.33M | 7.19M | 23.57M |
| Tangible Book Value Per Share | 3.13 | 3.13 | 2.81 | 0.00 | 0.00 | 0.02 |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -13.45M | -13.45M | -369.63K | -15.49M | -21.38M | -14.99M |
| Depreciation & Amortization | 662.96K | 662.96K | 662.89K | 662.99K | 663.19K | 764.37K |
| Loss (Gain) From Sale of Assets | 1.26K | |||||
| Asset Writedown & Restructuring Costs | 5.36M | 5.36M | ||||
| Stock-Based Compensation | 351.60K | 351.60K | 163.77K | 814.81K | 1.35M | 1.95M |
| Other Operating Activities | -1.22M | -1.22M | 117.03K | -2.12M | 150.97K | 1.15M |
| Change in Accounts Receivable | -801.48K | -801.48K | 114.94K | 299.20K | 4.14M | -26.97K |
| Change in Accounts Payable | -768.78K | -768.78K | -917.66K | 804.37K | 374.18K | 675.14K |
| Change in Other Net Operating Assets | -2.34M | -2.34M | 774.33K | 490.46K | 212.29K | -4.38M |
| Operating Cash Flow | -12.35M | -12.35M | 77.23K | -14.68M | -14.64M | -14.99M |
| Capital Expenditures | -1.06K | |||||
| Sale of Property, Plant & Equipment | 120.64K | |||||
| Investment in Securities | 300.15K | |||||
| Other Investing Activities | 8.62K | |||||
| Investing Cash Flow | 428.35K | |||||
| Long-Term Debt Repaid | -120.03K | |||||
| Lease Payments | -120.03K | |||||
| Net Debt Issued (Repaid) | -120.03K | |||||
| Issuance of Common Stock | 17.92M | 17.92M | 1.53M | 10.11M | 3.86M | 22.66M |
| Other Financing Activities | 5.00M | -3.94M | ||||
| Financing Cash Flow | 17.92M | 17.92M | 1.53M | 15.11M | 3.86M | 18.60M |
| Foreign Exchange Rate Adjustments | 14.03K | 14.03K | -3.75K | 76.97K | -243.82K | -548.73K |
| Net Cash Flow | 5.58M | 5.58M | 1.60M | 504.99K | -11.02M | 3.49M |
| Free Cash Flow | -12.35M | -12.35M | 77.23K | -14.68M | -14.64M | -14.99M |
| Free Cash Flow Margin | -1,052.07% | -1,052.07% | 0.49% | -359.30% | ||
| Free Cash Flow Per Share | -2.81 | -2.81 | 0.05 | -17.64 | -0.01 | -0.01 |
| Levered Free Cash Flow | -8.34M | -8.34M | 461.72K | -7.96M | -6.70M | -8.19M |
| Unlevered Free Cash Flow | -8.34M | -8.34M | 461.72K | -7.96M | -6.70M | -8.18M |
| Free Cash Flow After Leases | -12.35M | -12.35M | 77.23K | -14.68M | -14.64M | -15.11M |
| Cash Interest Paid | 3.86K | 3.86K | 17.43K | 31.52K | 30.43K | |
| Cash Income Tax Paid | 51.85K | |||||
| Change in Working Capital | -4.05M | -4.05M | -496.83K | 1.45M | 4.58M | -3.86M |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 16.50M | 23.62M | 13.35M | |||
| Enterprise Value | -3.33M | 4.21M | -3.52M | |||
| Last Close Price | 3.05 | 4.37 | 7.10 | |||
| PS Ratio | 14.06 | 20.11 | 0.85 | |||
| PB Ratio | 0.67 | 0.96 | 0.70 | |||
| P/TBV Ratio | 0.97 | 1.39 | 2.40 | |||
| P/FCF Ratio | 172.83 | |||||
| P/OCF Ratio | 172.83 | |||||
| EV/Sales Ratio | 3.59 | |||||
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 |
| Debt / FCF Ratio | 1.93 | |||||
| Net Debt / Equity Ratio | -0.81 | -0.81 | -0.74 | -0.70 | -0.53 | -0.58 |
| Net Debt / EBITDA Ratio | 2.38 | 2.38 | 84.56 | 0.72 | 0.56 | 1.97 |
| Net Debt / FCF Ratio | 1.60 | 1.60 | -182.08 | 0.84 | 0.80 | 1.51 |
| Asset Turnover | 0.04 | 0.04 | 0.56 | 0.10 | ||
| Quick Ratio | 27.33 | 27.33 | 3.37 | 3.33 | 4.58 | 12.02 |
| Current Ratio | 27.85 | 27.85 | 3.56 | 3.45 | 4.87 | 12.46 |
| Return on Equity (ROE) | -61.70% | -61.70% | -2.03% | -78.44% | -71.40% | -41.64% |
| Return on Assets (ROA) | -19.66% | -19.66% | -1.84% | -39.58% | -37.41% | -18.40% |
| Return on Capital Employed (ROCE) | -32.20% | -32.20% | -3.40% | -74.70% | -83.50% | -28.40% |
| Earnings Yield | -100.33% | -56.96% | -2.77% | |||
| FCF Yield | -74.85% | -52.30% | 0.58% | |||
| Buyback Yield / Dilution | -170.85% | -170.85% | -95.01% | 99.94% | -8.53% | -73.52% |